TITLE: Predictive factors for the outcome of multidisciplinary treatments in chronic
low back pain at the first multidisciplinary pain center of Japan

  ABSTRACT:
[Purpose] Multidisciplinary treatments are recommended for treatment of chronic low back
pain. The aim of this study was to show the associations among multidisciplinary treatment
outcomes, pretreatment psychological factors, self-reported pain levels, and history of
pain in chronic low back pain patients. [Subjects and Methods] A total of 221 chronic low
back pain patients were chosen for the study. The pretreatment scores for the 10-cm Visual
Analogue Scale, Hospital Anxiety and Depression Scale, Pain Catastrophizing Scale,
Short-Form McGill Pain Questionnaire, Pain Disability Assessment Scale, pain drawings, and
history of pain were collected. The patients were divided into two treatment outcome
groups a year later: a good outcome group and a poor outcome group. [Results] One-hundred
eighteen patients were allocated to the good outcome group. The scores for the Visual
Analogue Scale, Pain Disability Assessment Scale, and affective subscale of the Short-Form
McGill Pain Questionnaire and number of nonorganic pain drawings in the good outcome group
were significantly lower than those in the poor outcome group. Duration of pain in the
good outcome group was significantly shorter than in the poor outcome group. [Conclusion]
These findings help better predict the efficacy of multidisciplinary treatments in chronic
low back pain patients.

BODY.INTRODUCTION:
Chronic low back pain (LBP) is one of the most common long-term health problems in adults
in many countries. The prevalence of LBP in previous studies ranged from 18.6% to 57.4%1,2,3,4,5). Investigation of chronic pain, including
chronic LBP, has shifted from a purely biomedical model to a more holistic, biopsychosocial
one6). There is strong evidence
indicating that intensive multidisciplinary biopsychosocial treatments with a functional
restoration approach have improved function when compared with inpatient or outpatient
non-multidisciplinary treatments7).
Moreover, current guidelines generally advocate the use of multidisciplinary
cognitive-behavioral and exercise rehabilitation programs as first-line treatments8). However, it has been difficult for
clinicians to confirm efficacy, because chronic LBP is a complex, heterogeneous medical
condition that includes a wide variety of symptoms9). Some studies showed associations of treatment outcome with patient
characteristics, patient history, and psychological disturbance in chronic pain10,11,12,13).
Therefore, further assessment of treatments for chronic LBP patients has been needed.  Our center is the first multidisciplinary pain center in Japan and was established in July
2007. To date, there have been no reports of the effects of multidisciplinary treatments on
LBP in Japan. The purpose of this research was to show the associations among
multidisciplinary treatment outcomes, pretreatment psychological factors, self-reported pain
levels, and history of pain in chronic LBP patients.

BODY.SUBJECTS AND METHODS:
We included a total of 221 chronic LBP patients who visited the Pain Center of Aichi
Medical University between January 2010 and December 2011. Chronic LBP is defined as back
symptoms persisting for at least 3 months11). Our Pain Center has anesthesiologists, orthopedists,
psychiatrists, internists, dentists, nurses, physical therapists, and clinical
psychotherapists. All patients were referred from other medical institutions. Upon
presentation at our Pain Center for their first visit, the following data were collected for
all patients: a set of standardized self-report measures, demographics, symptoms, duration
of pain, education, and work status. Body mass index (BMI) was calculated from self-reported
height and self-reported weight by a nurse. Education status was divided into three
categories (junior high school, high school, and college). Work status was also divided into
three categories (working, sick leave, and unemployed). These data were extracted from
medical records after approval from the Ethics Committee of Aichi Medical University.  The 10-cm Visual Analogue Scale (VAS) (0 = no pain; 10 = worst pain imaginable) was used to
obtain the average intensity of total pain. The Hospital Anxiety and Depression Scale (HADS)
was designed to assess two separate dimensions of anxiety and depression. The HADS consists
of 14 items, with the anxiety (HADS-A) and depression (HADS-D) subscales each including 7
items. A four-point response scale (from 0, representing absence of symptoms, to 3,
representing maximum symptoms) was used, with possible scores for each subscale ranging from
0 to 2114, 15). The HADS is designed to avoid the use of somatic symptoms that may
confound other self-report measures of depression and anxiety14, 15). The Pain
Catastrophizing Scale (PCS) consists of 13 items, and subjects rate how frequently they have
experienced such cognition/emotions16, 17). The PCS is composed of three subscales:
rumination (e.g., "I keep thinking about how much it hurts"), magnification (e.g., "I wonder
whether something serious may happen"), and helplessness (e.g., "There is nothing I can do
to reduce the intensity of the pain")16, 17). The total score of the PCS can range from
0 to 5216, 17). The number of subjects who completed the PCS (n=101) was less than
the number of subjected who completed the other self-report measures (n=221), as we have
only recently begun to record it in our daily clinical practice. The Short-Form McGill Pain
Questionnaire (SF-MPQ) is comprised of 15 descriptors of pain and two scales for rating pain
intensity18). It is scored by
summarizing all words used to describe pain (0–15) and by counting the intensity assigned to
each word18). The sensory subscale of the
SF-MPQ includes descriptors 1–11, while descriptors 12–15 represent affective
interpretations18). The total score of
the SF-MPQ ranged from 0 to 4518). The
Pain Disability Assessment Scale (PDAS) assesses the degree to which chronic pain interfered
with various daily activities during the past week19). It includes 20 items reflecting pain interference in a broad range
of daily activities, and respondents indicate the extent to which pain interfered with
activities19). Scores for the total PDAS
range from 0 to 60, with higher scores indicating higher levels of pain interference19). Pain drawings are commonly used to
describe the location of pain reported by a patient. The pain drawings were classified
according to the principles described in several previous studies20,21,22), and scored with the nonorganic pain drawing scale on a
scale of 1 to 4: 1 = organic; 2 = possibly organic; 3 = possibly nonorganic; 4 = nonorganic.
The first author scored all pain drawings. Our previous study confirmed extremely high
inter-rater agreement regarding the four classifications of the pain drawings20). For ease of use, the organic and possibly
organic drawings were pooled into an "organic" group, and those classified as nonorganic or
possibly nonorganic were pooled into a "nonorganic" group as previously described20, 23, 24).  We administered treatment after a medical conference attended by different types of
professionals. As required, we administered pharmacological (including Kampo medicine,
traditional Japanese herbal medicine25)),
physical, acupuncture, cognitive-behavioral, and psychological treatments. Multidisciplinary
treatment was based on the biopsychosocial model of illness focusing on the operant and
cognitive-behavioral approach. The duration of treatment ranged from half an hour to an hour
per visit. The frequency of visits ranged from 1 to 2 times per month. We excluded patients
who had undergone surgery during the treatment period. Almost all patients were followed up
a year later, at which time we recorded the VAS score. Data other than the VAS score were
not recorded routinely in our daily clinical practice. We classified patients into two
groups: a good outcome group, for patients whose pain level decreased by at least 50%
according to the VAS score compared with before treatment, and a poor outcome group for
patients whose pain level did not26,27,28,29).  All data are expressed as the mean ± standard deviation of the mean (SD). The data were
analyzed using the PASW Statistics software (version 18.0 for Windows, SPSS Inc, Chicago,
IL, USA). The χ2 test, Mann-Whitney U test, and Spearman's rank correlation
coefficient test were used for statistical analysis. P<0.05 was considered statistically
significant.

BODY.RESULTS:
One-hundred eighteen patients (53.3%) were divided into the good outcome group, and 103
patients (46.7%) were divided into the poor outcome group. There were no significant
differences in patient characteristics or daily life factors between the good outcome and
poor outcome groups (Table 1Table 1.Comparison of patient characteristics and daily life factorsGood groupPoor group(n = 118)(n = 103)Age56.8 ± 16.758.1 ± 14.6BMI22.3 ± 3.322.4 ± 3.2 GenderMale71 (60%)67 (65%)Female47 (40%)36 (35%)Education history Junior high school 22 (19%)18 (17%)High school48 (41%)52 (51%)College39 (33%)28 (27%)No data9 (7%)5 (5%)WorkWorking43 (36%)33 (32%)Sick leave13 (11%)14 (14%)Unemployment 62 (53%)56 (54%)Sleep disorder+92 (78%)81 (79%)−26 (22%)22 (21%)Drinking habit+32 (27%)28 (27%)−86 (73%)75 (73%)Smoking habit+10 ( 8%)11 (11%)−108 (92%)92 (89%)Exercising habit +65 (55%)57 (55%)−53 (45%)46 (45%)BMI: body mass index. Data for gender, education history, work, sleep disorder,
drinking habit, smoking habit, and exercising habit are shown as numbers and
percentages (in parentheses) of patients who replied subjectively with "yes." These
data were analyzed by the χ2 test. Data for age and BMI are shown as the
mean ± standard deviation of the mean (SD). These data were analyzed by the
Mann-Whitney U test. The significance level is less than 5%. There were no significant
differences in patient characteristics and daily life factors between outcome
groups.). As shown in Table 2
Table 2.Comparison of pretreatment scores for self-report measures between outcome
groups, the pretreatment scores for the VAS, HADS, PCS, SF-MPQ, PDAS, and pain
drawings were compared between the outcome groups. Fewer subjects completed the PCS compared
with the other self-report measures (Table 2).
The HADS, sensory subscale of the SF-MPQ, and PCS scores did not show significant
differences between the groups. On the other hand, the VAS, PDAS, and affective subscale of
the SF-MPQ showed significantly lower scores in the good outcome group compared with the
poor outcome group. Regarding the pain drawings, there were significantly fewer nonorganic
pain drawings in the good outcome group (n=35/118) than in the poor outcome group
(n=47/103). As shown in Table 3Table 3. Characteristic of daily painGood group(n = 118)Poor group(n = 103)Pain at rest+77 (65%)79 (77%)−41 (35%)24 (23%)Pain during motion+61 (52%)53 (51%)−57 (48%)50 (49%)Painful to the touch+14 (12%)16 (16%)−104 (88%)87 (84%)Pain changing with the weather+91 (77%)77 (75%)−27 (23%)26 (25%)Painful at night *+25 (21%)36 (35%)−93 (79%)67 (65%)Painful in the morning*+33 (28%)17 (17%)−85 (72%)86 (83%)Pain reduced in daytime+11 ( 9%)6 ( 6%)−107 (91%)97 (94%)Pain unaltered during day+45 (38%)47 (46%)−73 (62%)56 (54%)Pain changing during day+55 (47%)46 (45%)−63 (53%)57 (55%)Data for paint at rest, pain during motion, painful to the touch, pain changing with
the weather, painful at night, painful in the morning, pain reduced in daytime, pain
unaltered during day, and pain changing during day are shown as numbers and
percentages (in parentheses) of patients who replied subjectively with "yes." These
data were analyzed by the χ2 test. The significance level is less than 5%.
*: Different between good and poor groups. There were significantly fewer patients
reporting painful at night in the good outcome group than the poor outcome group.
There were significantly more patients reporting painful in the morning in the good
outcome group than the poor outcome group. There were no significant differences for
the other characteristics between the outcome groups., characteristics of daily pain were investigated between the two outcome
groups. The results showed that the number of patients who experienced pain at night in the
good outcome group (n=25/118) was significantly lower than that in the poor outcome group
(n=36/103). Furthemore, the number of patients who experienced pain in the morning in the
good outcome group (n=33/118) was significantly greater than that in the poor outcome group
(n=17/103). As shown in Table 4Table 4.Course of development of painGood groupPoor group(n = 103)Duration of pain (y) *<145 (38%)24 (23%)≥173 (62%)79 (77%)Pain development By gradation)66 (56%67 (65%)Rapidly52 (44%)36 (35%)Cause of injuryTraffic accident7 ( 6%)9 ( 9%)Work-related injury 1 ( 1%)2 ( 2%)Unclear110 (93%)92 (89%)Data for duration of pain, pain development, and cause of injury are shown as numbers
and percentages (in parentheses) of patients who replied subjectively with "yes."
These data were analyzed by the χ2 test. The significance level is less
than 5%. *: Different between good and poor groups. The durations of pain in the good
outcome group were significantly shorter than those in the poor outcome group. There
were no significant differences in the other items concerning the course of
development of pain between the outcome groups., the duration of pain in the good outcome group was significantly shorter than
in the poor outcome group. The other items in the course of development of pain did not show
significant differences between the two outcome groups (Table 4).

BODY.DISCUSSION:
In the present study, the pretreatment scores for the VAS, PDAS, affective subscale of the
SF-MPQ, and pain drawings were associated with outcomes in the chronic LBP patients.
Pretreatment status predicted treatment outcome in chronic pain patients10,11,12,13).
This is the first report to show the association between the PDAS and multidisciplinary
treatment outcomes. The PDAS reflects pain interference in a broad range of daily
activities, and respondents indicate the extent to which pain interferes with
activities19). This might help us better
predict the efficacy of multidisciplinary treatments in chronic LBP patients.  The results regarding the characteristics of daily pain revealed that the number of
patients who experienced pain at night and the number of patients who experienced pain in
the morning were significantly lower and higher, respectively, in the good outcome group
than in the poor outcome group. These findings suggest that the patients who got
progressively worse during the day had poor outcomes. The findings indicated that assessment
of chronic LBP patients could require not only psychological questionnaires but also
standard medical interviews.  The pretreatment scores for catastrophizing were not consistently associated with the
outcomes. In previous systematic reviews of nonspecific chronic LBP, although a decrease in
catastrophizing was accompanied by an increase in daily activities and a decrease in pain
levels, pretreatment scores for catastrophizing were not consistently associated with
outcomes30).  There were several limitations in this study. The multidisciplinary treatments offered in
this study differed from the norm of offering 1–2 sessions per week for 6–12 consecutive
weeks7). However, 53.3% of the patients
were in the good outcome group in the present study, which was not much different from the
rates in previous studies28, 31,32,33). In addition, physical function and quality of life were
not investigated after treatment in the present study. The treatment goals for the chronic
pain patients were not only pain intensity. Further studies are needed using
multidimensional outcomes. This study included only a small number of patients from a single
medical center. Furthermore, the number of the subjects assessed with the PCS, was
particularly small in the present study. The results of the present study must be
interpreted with caution.  In conclusion, poor outcomes were related to high pretreatment scores for the VAS, PDAS,
and affective subscale of the SF-MPQ; nonorganic pain drawings; longer duration of pain; and
pain that progressively worsened for days in chronic LBP patients who received
multidisciplinary treatments for a year.

Question: Compared to poor outcome group what was the result of good outcome group on Duration of pain?
Evidence: The scores for the Visual
Analogue Scale, Pain Disability Assessment Scale, and affective subscale of the Short-Form
McGill Pain Questionnaire and number of nonorganic pain drawings in the good outcome group
were significantly lower than those in the poor outcome group. 
Answer: significantly decreased